logo-loader
viewInstem PLC

Instem PLC reports strong demand for its informatics services

Instem PLC's (LON:INS) chief scientific officer and head of its informatics arm Dr Gordon Smith Baxter tells Proactive London the value of new orders for the division has grown by 58% to £840,000.

He says the firm's expansion into informatics is bringing them into contact with customers at an early stage in the drug development process.

Quick facts: Instem PLC

Price: 510.001 GBX

AIM:INS
Market: AIM
Market Cap: £104.46 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Instem PLC named herein, including the promotion by the Company of Instem PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Instem PLC has 'significant capital' to accelerate acquisition strategy...

Instem PLC's (LON:INS) Phil Reason tells Proactive London's Andrew Scott he's pleased with its first-half trading. He says the number's were in line with forecasts and momentum has continued into the second half. Revenues for the six months ended June 30, 2020, were up 20%, or 12% on a...

2 weeks, 1 day ago

2 min read